Match tier Likely match
Presence Current · Arkansas
Last published 2023
Sources OpenAlex · ORCID
Refreshed 2026-08-08

David F. Gilmore

This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.

Researcher

Also affiliated: University of Connecticut (1989); University of Massachusetts Amherst (1992–1997); Indiana University Bloomington (1989)

Faculty Researcher

19 h-index 36 pubs 1,016 cited

  • Microbial Sensitivity Tests
  • Humans
  • Animals
  • Anti-Bacterial Agents
  • Staphylococcus aureus
  • Pyrazoles
  • Biofilms
  • Structure-Activity Relationship
  • Drug Resistance, Bacterial
  • Acinetobacter baumannii
  • Fatty Acids
  • Chiroptera
  • Gas Chromatography-Mass Spectrometry
  • Anti-Infective Agents
  • Methicillin-Resistant Staphylococcus aureus

Biography and Research Information

OverviewAI-generated summary

David F. Gilmore's research focuses on the design, synthesis, and evaluation of novel pyrazole derivatives as antibacterial agents. His work investigates their potency against Gram-positive bacteria, including Staphylococcus aureus and Enterococcus species, as well as Gram-negative bacteria such as Acinetobacter baumannii. Gilmore has explored structure-activity relationships, particularly concerning substituents on the phenyl rings and benzoic acid moieties, to optimize antimicrobial efficacy. His research also extends to the development of pyrazole derivatives that act as inhibitors of fatty acid biosynthesis in bacteria. Gilmore has a publication record of 36 papers, with an h-index of 19 and 977 total citations. He has collaborated with several faculty members at Arkansas State University, including Mohammad A. Alam, Hansa Raj KC, Subrata Roy, and Mohd Kotaiba Abugazleh.

Metrics

  • h-index: 19
  • Publications: 36
  • Citations: 1,016

Selected Publications

  • Development and Antibacterial Properties of 4-[4-(Anilinomethyl)-3-phenylpyrazol-1-yl]benzoic Acid Derivatives as Fatty Acid Biosynthesis Inhibitors (2023)
    Journal of Medicinal Chemistry 16 citations DOI OpenAlex
  • Development of 4-[4-(Anilinomethyl)-3-phenyl-pyrazol-1-yl] Benzoic Acid Derivatives as Potent Anti-Staphylococci and Anti-Enterococci Agents (2022)
    Antibiotics 9 citations DOI OpenAlex
  • Novel Pyrazoles As Potent Growth Inhibitors of Staphylococci, Enterococci and <i>Acinetobacter Baumannii</i> Bacteria (2021)
    Future Medicinal Chemistry 13 citations DOI OpenAlex
  • Design, synthesis, and antibacterial activity of <i>N</i> -(trifluoromethyl)phenyl substituted pyrazole derivatives (2021)
    RSC Medicinal Chemistry 33 citations DOI OpenAlex
  • Synthesis of 3,5-Bis(trifluoromethyl)phenyl-Substituted Pyrazole Derivatives as Potent Growth Inhibitors of Drug-Resistant Bacteria (2021)
    Molecules 8 citations DOI OpenAlex
  • Synthesis of Chimeric Thiazolo‐Nootkatone Derivatives as Potent Antimicrobial Agents (2021)
    ChemMedChem 24 citations DOI OpenAlex
  • 4-4-(Anilinomethyl)-3-[4-(trifluoromethyl)phenyl]-1H-pyrazol-1-ylbenzoic acid derivatives as potent anti-gram-positive bacterial agents (2021)
    European Journal of Medicinal Chemistry 31 citations DOI OpenAlex
  • Synthesis of 4,4′-(4-Formyl-1H-pyrazole-1,3-diyl)dibenzoic Acid Derivatives as Narrow Spectrum Antibiotics for the Potential Treatment of Acinetobacter Baumannii Infections (2020)
    Antibiotics 20 citations DOI OpenAlex
  • Design and synthesis of 4-[4-formyl-3-(2-naphthyl)pyrazol-1-yl]benzoic acid derivatives as potent growth inhibitors of drug-resistant Staphylococcus aureus (2020)
    The Journal of Antibiotics 21 citations DOI OpenAlex
  • Synthesis and Antimicrobial Studies of Coumarin-Substituted Pyrazole Derivatives as Potent Anti-Staphylococcus aureus Agents (2020)
    Molecules 61 citations DOI OpenAlex
  • Synthesis and Antimicrobial Studies of 4-[3-(3-Fluorophenyl)-4-formyl-1<i>H</i>-pyrazol-1-yl]benzoic Acid and 4-[3-(4-Fluorophenyl)-4-formyl-1<i>H</i>-pyrazol-1-yl]benzoic Acid as Potent Growth Inhibitors of Drug-Resistant Bacteria (2019)
    ACS Omega 31 citations DOI OpenAlex
  • Synthesis of Hydrazone Derivatives of 4-[4-Formyl-3-(2-oxochromen-3-yl)pyrazol-1-yl]benzoic acid as Potent Growth Inhibitors of Antibiotic-resistant Staphylococcus aureus and Acinetobacter baumannii (2019)
    Molecules 28 citations DOI OpenAlex
  • Synthesis and antimicrobial studies of hydrazone derivatives of 4-[3-(2,4-difluorophenyl)-4-formyl-1H-pyrazol-1-yl]benzoic acid and 4-[3-(3,4-difluorophenyl)-4-formyl-1H-pyrazol-1-yl]benzoic acid (2018)
    Bioorganic & Medicinal Chemistry Letters 38 citations DOI OpenAlex
  • Molecular identification of common Salmonella serovars using multiplex DNA sensor-based suspension array (2018)
    Analytical and Bioanalytical Chemistry 20 citations DOI OpenAlex
  • Synthesis and antimicrobial studies of novel derivatives of 4-(4-formyl-3-phenyl-1H-pyrazol-1-yl)benzoic acid as potent anti-Acinetobacter baumannii agents (2016)
    Bioorganic & Medicinal Chemistry Letters 42 citations DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

21 Collaborators 3 Institutions 1 Country

Top Collaborators

View profile →
View profile →
View profile →
View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics